TregTherapeutics Inc.
www.tregtherapeutics.comTregTherapeutics Inc. is a preclinical stage company focused on the treatment and cure of multiple sclerosis. The objective of the TregTherapeutics tolerogenic vaccine is to reverse the inflammatory T cell immune attack in demyelinating lesions of an MS patient, and subsequently, to create an anti-inflammatory tolerogenic response within that patient.
Read more
TregTherapeutics Inc. is a preclinical stage company focused on the treatment and cure of multiple sclerosis. The objective of the TregTherapeutics tolerogenic vaccine is to reverse the inflammatory T cell immune attack in demyelinating lesions of an MS patient, and subsequently, to create an anti-inflammatory tolerogenic response within that patient.
Read more
Country
State
North Carolina
City (Headquarters)
Chapel Hill
Industry
Employees
1-10
Founded
2018
Social
Employees statistics
View all employeesPotential Decision Makers
Managing Partner
Email ****** @****.comPhone (***) ****-****President
Email ****** @****.comPhone (***) ****-****
Reach decision makers at TregTherapeutics Inc.
Free credits every month!
TregTherapeutics Inc. FAQ
Chapel Hill, United States
Biotechnology Research
